HomeStock ScreenerSanofi Consumer Healthcare

Sanofi Consumer Healthcare Share Price | Sanofi Consumer Healthcare Stock Screener

SANOFICONR Pharmaceuticals
Share Price NSE
₹4674.70
▲ 22.60 (0.49%)
2026-07-24 00:00:00
Share Price BSE
₹4681.70
▲ 35.60 (0.77%)
2026-07-24 00:00:00
As of July 24, 2026, the Sanofi Consumer Healthcare share price (NSE: SANOFICONR) is ₹4,674.70 on NSE and ₹4,681.70 on BSE, up 0.49% from the previous close, with shares trading between ₹4,552.00 and ₹4,709.30, and a 52-week range of ₹3,999.50–₹5,366.50. Analyse SANOFICONR share price history and track historical price performance. Use the Sanofi Consumer Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sanofi Consumer Healthcare Market Cap ₹10,434.94 Cr.
SANOFICONR P/E Ratio (TTM) 40.75
Sanofi Consumer Healthcare P/B Ratio 27.36
EPS (TTM) ₹104.27
Dividend Yield 1.64%
Debt to Equity 0.07
SANOFICONR 52 Week High ₹5366.50
Sanofi Consumer Healthcare 52 Week Low ₹3999.50
Operating Margin 35.00%
Profit Margin 26.76%
SANOFICONR Revenue (TTM) ₹897.00
EBITDA ₹327.00
Net Income ₹240.00
Total Assets ₹547.00
Total Equity ₹384.00

Sanofi Consumer Healthcare Share Price Chart

Screen Sanofi Consumer Healthcare share price with an interactive chart. Analyse SANOFICONR price trends and volatility across different timeframes.

Sanofi Consumer Healthcare Company Profile - Fundamental Screener

Screen Sanofi Consumer Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANOFICONR shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE0UOS01011

Sanofi Consumer Healthcare Balance Sheet Screener

Screen SANOFICONR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023
Assets
Total Assets 547 431 345
Current Assets 494 392 335
Fixed Assets 36 29 5
Liabilities
Total Liabilities 0 0 0
Current Liabilities 35 28 8
Non-Current Liabilities 0 0 0
Shareholders' Equity
Total Equity 384 273 208
Share Capital 23 23 2
Reserves & Surplus 361 250 183

Sanofi Consumer Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Sanofi Consumer Healthcare income statement and profit fundamentals. Analyze SANOFICONR quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sanofi Consumer Healthcare share price evaluation.
Item 2025-March 2024-March 2023-March
Revenue 897 738 560
Expenses 569 454 337
EBITDA 327 284 223
Operating Profit % 35.00% 37.00% 39.00%
Depreciation 12 5 2
Interest 2 4 0
Profit Before Tax 320 247 219
Tax 80 66 54
Net Profit 240 181 165
EPS 104.27 78.59 71.60

Sanofi Consumer Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen SANOFICONR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March
Operating Activities 175 439 0
Investing Activities 8 2 0
Financing Activities -135 -116 2
Net Cash Flow 48 325 2

Sanofi Consumer Healthcare Shareholding Pattern Screener

See Sanofi Consumer Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Sanofi Consumer Healthcare promoter holding and ownership changes for SANOFICONR on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Jun 2024-Sept 2024-Oct
Promoter Holding 71.27% 60.40% 71.27% 71.27% 71.27% 60.40% 60.40% 60.40%
FII Holding 2.76% 4.53% 3.24% 2.94% 2.83% 0.00% 5.22% 4.87%
DII Holding 17.57% 25.48% 16.89% 17.21% 17.33% 20.87% 24.03% 24.51%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 6.26% 6.58% 6.30% 6.26% 6.25% 7.71% 7.53% 7.41%
Other Holding 2.14% 3.01% 2.30% 2.32% 2.31% 11.03% 2.83% 2.82%
Shareholder Count 48,418 51,859 49,632 48,808 48,075 61,091 61,091 57,598

Sanofi Consumer Healthcare Share Dividend Screener - Share Yield Analysis

Check Sanofi Consumer Healthcare dividend history with payout and yield data. View Sanofi Consumer Healthcare dividend details including ex-dates and amounts for SANOFICONR stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹75.00 1.74%
2024-March ₹55.00 1.14%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Sanofi Consumer Healthcare Stock Index Membership

See which indices include Sanofi Consumer Healthcare stock. Check SANOFICONR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT

Sanofi Consumer Healthcare Market Events Screener - Corporate Actions

Get Sanofi Consumer Healthcare corporate actions including splits, bonuses, and buybacks. Check Sanofi Consumer Healthcare stock events that may affect SANOFICONR share price.
Announcement Date Record Date Event Type Information Price Impact
2026-06-26 2026-06-26 Annual General Meeting NA -0.48%
2026-06-19 2026-06-19 Dividend ₹ 75.00 /share 23.74%
2026-04-28 2026-04-28 Quarterly Result Announcement NA 1.44%
2026-02-25 2026-02-25 Quarterly Result Announcement NA -4.76%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -5.69%
2025-08-04 2025-08-04 Quarterly Result Announcement NA -2.10%
2025-05-05 2025-05-05 Annual General Meeting NA 3.98%
2025-05-02 2025-05-02 Quarterly Result Announcement NA 0.05%
2025-04-17 2025-04-17 Dividend ₹ 55.00 /share 5.10%
2025-02-20 2025-02-20 Quarterly Result Announcement NA 0.62%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 0.78%

Sanofi Consumer Healthcare Competitors Screener - Peer Comparison

Screen SANOFICONR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 466,095 40.90 61,674 12.69% 11,565 68.02
Divis Laboratories 195,743 75.78 11,067 13.95% 2,568 71.98
Torrent Pharmaceuticals 189,731 79.75 13,886 20.34% 2,138 66.68
Cipla 113,720 29.97 29,045 2.24% 3,870 52.50
Zydus Life Science 112,698 22.27 27,658 17.64% 5,026 58.19
Lupin 110,883 21.47 29,039 26.75% 5,356 63.60
Mankind Pharma 105,409 54.93 14,636 14.85% 1,938 60.75
Dr Reddys Laboratories 99,184 24.22 35,059 3.90% 4,158 32.84
Aurobindo Pharma 87,993 26.21 33,385 3.21% 3,376 58.93
Laurus Labs 85,562 96.66 6,868 22.01% 890 67.71

Sanofi Consumer Healthcare Company Announcements - News Screener

Screen SANOFICONR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-29 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-06-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-06-26 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-06-26 Closure of Trading Window -
2026-06-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-06-04 Shareholder Meeting - AGM On 26Th June 2026 -
2026-06-04 Shareholder Meeting - AGM On 26Th June 2026 -
2026-06-04 Reg. 34 (1) Annual Report. -
2026-06-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-27 Intimation Of Record Date For Payment Of Final Dividend For FY 2025 -
2026-05-27 Intimation Of Book Closure For Payment Of Final Dividend For Fy 2025 -
2026-05-27 Intimation Of 3Rd Annual General Meeting Of The Company -
2026-05-25 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-05-25 Board Meeting Outcome for Intimation Of Appointment Of Statutory Auditor Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-05-05 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-04-30 Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors -
2026-04-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-04-30 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-04-28 Results - Financial Results For March 31 2026 -